Author:
Vas Krisztina Eszter,Szász Izabella,Molnár Szabolcs,Lőrinczi Lilla,Székely Edit
Reference90 articles.
1. Clinical features and treatment outcomes of vancomycin - intermediate Staphylococcus aureus VISA and heteroresistant vancomycin - intermediate Staphylococcus aureus hVISA in a tertiary care institution in Singapore;Fong;Eur J Clin Microbiol Infect Dis,2009
2. FC The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus Agents Chemoter;Tenover,2007
3. Emergence of vancomycin - intermediate Staphylococcus aureus in a Belgian hospital : microbiological and clinical features;Denis,2002
4. Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two hospitals;Reverdy;Clin Microbiol,2001
5. multi - center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus heterogeneous;Voss;Ann Clin Microbiol,2007
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献